Abstract

Mendelian randomization is a promising approach to help improve causal inference in observational studies, with widespread potential applications, including to prioritization of pharmacotherapeutic targets for evaluation in RCTs. From its initial proposal the limitations of Mendelian randomization approaches have been widely recognised and discussed, and recently Pickrell has reiterated these1. However this critique did not acknowledge recent developments in both methodological and empirical research, nor did it recognise many future opportunities for application of the Mendelian randomization approach. These issues are briefly reviewed here.

Keywords

Mendelian randomizationCausal inferenceObservational studyRandomizationPrioritizationInferenceMendelian inheritanceComputer scienceRisk analysis (engineering)MedicineBiologyClinical trialBioinformaticsManagement scienceEngineeringArtificial intelligenceGeneticsGenetic variantsInternal medicinePathology

Affiliated Institutions

Related Publications

Publication Info

Year
2015
Type
preprint
Citations
13
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

13
OpenAlex

Cite This

George Davey Smith (2015). Mendelian randomization: a premature burial?. bioRxiv (Cold Spring Harbor Laboratory) . https://doi.org/10.1101/021386

Identifiers

DOI
10.1101/021386